Veterinary Medicines

LABIMYCIN LA 300 mg/ml SOLUTION FOR INJECTION

Authorised
  • Oxytetracycline dihydrate
Download as PDF

Product identification

Medicine name:
LABIMYCIN LA 300 mg/ml SOLUTION FOR INJECTION
Labimycin LA 300 mg/ml oldatos injekció szarvasmarhák , juhok és sertések részére
Active substance:
  • Oxytetracycline dihydrate
Target species:
  • Pig
  • Cattle
  • Sheep
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Oxytetracycline dihydrate
    323.18
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        28
        day
    • Cattle
      • Meat and offal
        35
        day
      • Milk
        7
        day
    • Sheep
      • Meat and offal
        35
        day
      • Milk
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Box with 10 Vials of 250 ml
  • Box with 10 Vials of 100 ml
  • Box with 12 Vials of 50 ml
  • Box with 1 vial of 250 ml
  • Box with 1 vial of 100 ml
  • Box with 1 Vial of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 4320/X/22 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0406/001
Concerned member states:
  • Greece
  • Hungary
  • Portugal
  • Romania

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."